{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:09:43Z","timestamp":1762459783593,"version":"3.40.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2011\/05807-4","2012\/00978-8"],"award-info":[{"award-number":["2011\/05807-4","2012\/00978-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["152538\/2012-7"],"award-info":[{"award-number":["152538\/2012-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10616-019-00337-y","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T13:02:27Z","timestamp":1566046947000},"page":"949-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Semliki Forest Virus replicon particles production in serum-free medium BHK-21 cell cultures and their use to express different proteins"],"prefix":"10.1007","volume":"71","author":[{"given":"Sandra Fernanda","family":"Su\u00e1rez-Pati\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaissa Consoni","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eutimio Gustavo Fern\u00e1ndez","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato Mancini","family":"Astray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Augusto","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana S.","family":"Coroadinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraia Attie Calil","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,17]]},"reference":[{"key":"337_CR1","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijbiomac.2015.09.010","volume":"81","author":"SP Ajbani","year":"2015","unstructured":"Ajbani SP, Velhal SM, Kadam RB et al (2015) Immunogenicity of Semliki Forest Virus based self-amplifying RNA expressing Indian HIV-1C genes in mice. Int J Biol Macromol 81:794\u2013802. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.09.010","journal-title":"Int J Biol Macromol"},{"key":"337_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/biot.200700179","volume":"3","author":"RM Astray","year":"2008","unstructured":"Astray RM, Augusto E, Yokomizo AY, Pereira CA (2008) Analytical approach for the extraction of recombinant membrane viral glycoprotein from stably transfected Drosophila melanogaster cells. Biotechnol J 3:98\u2013103. https:\/\/doi.org\/10.1002\/biot.200700179","journal-title":"Biotechnol J"},{"key":"337_CR3","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.vaccine.2014.02.029","volume":"32","author":"RM Astray","year":"2014","unstructured":"Astray RM, Ventini DC, Boldorini VLL et al (2014) Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors. Vaccine 32:2829\u20132832. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.029","journal-title":"Vaccine"},{"key":"337_CR4","first-page":"55","volume":"35","author":"SJ Barteling","year":"1976","unstructured":"Barteling SJ (1976) Certain aspects of foot-and-mouth disease. Virus production in growing BHK suspended cell cultures. Dev Biol Stand 35:55\u201360","journal-title":"Dev Biol Stand"},{"key":"337_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0264-410X(91)90261-4","volume":"9","author":"SJ Barteling","year":"1991","unstructured":"Barteling SJ, Vreeswijk J (1991) Developments in foot-and-mouth disease vaccines. Vaccine 9:75\u201388","journal-title":"Vaccine"},{"key":"337_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jbiotec.2008.12.009","volume":"139","author":"R Benmaamar","year":"2009","unstructured":"Benmaamar R, Astray RM, Wagner R, Pereira CA (2009) High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector. J Biotechnol 139:283\u2013290. https:\/\/doi.org\/10.1016\/j.jbiotec.2008.12.009","journal-title":"J Biotechnol"},{"issue":"8","key":"337_CR7","first-page":"916","volume":"11","author":"P Berglund","year":"1993","unstructured":"Berglund P, Sj\u00f6berg M, Garoff H et al (1993) Semliki forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (N Y) 11(8):916\u2013920","journal-title":"Biotechnology (N Y)"},{"key":"337_CR8","first-page":"93","volume":"98","author":"R Brands","year":"1999","unstructured":"Brands R, Visser J, Medema J et al (1999) Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Stand 98:93\u2013100 (discussion 111)","journal-title":"Dev Biol Stand"},{"key":"337_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1099\/0022-1317-72-2-359","volume":"72","author":"SR Burger","year":"1991","unstructured":"Burger SR, Remaley AT, Danley JM et al (1991) Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells. J Gen Virol 72:359\u2013367. https:\/\/doi.org\/10.1099\/0022-1317-72-2-359","journal-title":"J Gen Virol"},{"key":"337_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1006\/cbir.1993.1152","volume":"17","author":"J Cinatl","year":"1993","unstructured":"Cinatl J, Cinatl J, Rabenau H et al (1993) Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses. Cell Biol Int 17:885\u2013895. https:\/\/doi.org\/10.1006\/cbir.1993.1152","journal-title":"Cell Biol Int"},{"key":"337_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nbt.2012.12.002","volume":"30","author":"AR Costa","year":"2013","unstructured":"Costa AR, Withers J, Rodrigues ME et al (2013) The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells. N Biotechnol 30:563\u2013572. https:\/\/doi.org\/10.1016\/j.nbt.2012.12.002","journal-title":"N Biotechnol"},{"key":"337_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1007951813755","volume":"26","author":"HJ Cruz","year":"1998","unstructured":"Cruz HJ, Moreira JL, Stacey G et al (1998) Adaptation of BHK cells producing a recombinant protein to serum-free media and protein-free medium. Cytotechnology 26:59\u201364. https:\/\/doi.org\/10.1023\/A:1007951813755","journal-title":"Cytotechnology"},{"key":"337_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-015-1991-1","author":"RLF do Amaral","year":"2015","unstructured":"do Amaral RLF, de SousaBomfim A, de Abreu-Neto MS et al (2015) Approaches for recombinant human factor IX production in serum-free suspension cultures. Biotechnol Lett. https:\/\/doi.org\/10.1007\/s10529-015-1991-1","journal-title":"Biotechnol Lett"},{"key":"337_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10529-015-1787-3","volume":"37","author":"EG Fern\u00e1ndez-N\u00fa\u00f1ez","year":"2015","unstructured":"Fern\u00e1ndez-N\u00fa\u00f1ez EG, de Rezende AG, Puglia ALP et al (2015) Transient expression of rabies virus G-glycoprotein using BHK-21 cells cultured in suspension. Biotechnol Lett 37:1153\u20131163. https:\/\/doi.org\/10.1007\/s10529-015-1787-3","journal-title":"Biotechnol Lett"},{"key":"337_CR15","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1016\/j.vaccine.2015.03.088","volume":"33","author":"D Fontana","year":"2015","unstructured":"Fontana D, Kratje R, Etcheverrigaray M, Prieto C (2015) Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine 33:4238\u20134246. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.088","journal-title":"Vaccine"},{"key":"337_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.vaccine.2004.06.014","volume":"23","author":"NM Frazatti-Gallina","year":"2004","unstructured":"Frazatti-Gallina NM, Mour\u00e3o-Fuches RM, Paoli RL et al (2004) Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23:511\u2013517. https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.014","journal-title":"Vaccine"},{"key":"337_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.smim.2013.05.001","volume":"25","author":"AJ Geall","year":"2013","unstructured":"Geall AJ, Mandl CW, Ulmer JB (2013) RNA: the new revolution in nucleic acid vaccines. Semin Immunol 25:152\u2013159. https:\/\/doi.org\/10.1016\/j.smim.2013.05.001","journal-title":"Semin Immunol"},{"key":"337_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/biot.201400388","volume":"10","author":"Y Genzel","year":"2015","unstructured":"Genzel Y (2015) Designing cell lines for viral vaccine production: where do we stand? Biotechnol J 10:728\u2013740. https:\/\/doi.org\/10.1002\/biot.201400388","journal-title":"Biotechnol J"},{"key":"337_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(99)00104-0","volume":"229","author":"UA Hasan","year":"1999","unstructured":"Hasan UA, Abai AM, Harper DR et al (1999) Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J Immunol Methods 229:1\u201322","journal-title":"J Immunol Methods"},{"key":"337_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mca04hs17","author":"R Hernandez","year":"2010","unstructured":"Hernandez R, Brown DT (2010) Growth and maintenance of baby hamster kidney (BHK) cells. Curr Protoc Microbiol. https:\/\/doi.org\/10.1002\/9780471729259.mca04hs17","journal-title":"Curr Protoc Microbiol"},{"key":"337_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0167-7799(99)01420-1","volume":"18","author":"F Hesse","year":"2000","unstructured":"Hesse F, Wagner R (2000) Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. Trends Biotechnol 18:173\u2013180","journal-title":"Trends Biotechnol"},{"key":"337_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/bit.21177","volume":"96","author":"RB Hitchman","year":"2007","unstructured":"Hitchman RB, Siaterli EA, Nixon CP, King LA (2007) Quantitative real-time PCR for rapid and accurate titration of recombinant baculovirus particles. Biotechnol Bioeng 96:810\u2013814. https:\/\/doi.org\/10.1002\/bit.21177","journal-title":"Biotechnol Bioeng"},{"key":"337_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2009.04.034","volume":"139","author":"B Hoffmann","year":"2009","unstructured":"Hoffmann B, Beer M, Reid SM et al (2009) A review of RT-PCR technologies used in veterinary virology and disease control: sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health. Vet Microbiol 139:1\u201323. https:\/\/doi.org\/10.1016\/j.vetmic.2009.04.034","journal-title":"Vet Microbiol"},{"key":"337_CR24","doi-asserted-by":"publisher","first-page":"e0141686","DOI":"10.1371\/journal.pone.0141686","volume":"10","author":"D Huang","year":"2015","unstructured":"Huang D, Peng W-J, Ye Q et al (2015) Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines. PLoS ONE 10:e0141686. https:\/\/doi.org\/10.1371\/journal.pone.0141686","journal-title":"PLoS ONE"},{"key":"337_CR25","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.3748\/wjg.v19.i47.8929","volume":"19","author":"J Hundt","year":"2013","unstructured":"Hundt J, Li Z, Liu Q (2013) Post-translational modifications of hepatitis C viral proteins and their biological significance. World J Gastroenterol 19:8929\u20138939. https:\/\/doi.org\/10.3748\/wjg.v19.i47.8929","journal-title":"World J Gastroenterol"},{"key":"337_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0168-1656(02)00009-3","volume":"95","author":"H Kallel","year":"2002","unstructured":"Kallel H, Jouini A, Majoul S, Rourou S (2002) Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. J Biotechnol 95:195\u2013204","journal-title":"J Biotechnol"},{"key":"337_CR27","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1007\/s00253-013-4939-1","volume":"97","author":"S Kluge","year":"2013","unstructured":"Kluge S, Rourou S, Vester D et al (2013) Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media. Appl Microbiol Biotechnol 97:5493\u20135506. https:\/\/doi.org\/10.1007\/s00253-013-4939-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"337_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jbiotec.2018.03.010","volume":"274","author":"MAN Lemos","year":"2018","unstructured":"Lemos MAN, Pati\u00f1o SFS, Bernardino TC et al (2018) Intracellular delivery of HCV NS3p gene using vectored particles. J Biotechnol 274:33\u201339. https:\/\/doi.org\/10.1016\/j.jbiotec.2018.03.010","journal-title":"J Biotechnol"},{"key":"337_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1099\/vir.0.016881-0","volume":"91","author":"JMP Liefhebber","year":"2010","unstructured":"Liefhebber JMP, Hensbergen PJ, Deelder AM et al (2010) Characterization of hepatitis C virus NS3 modifications in the context of replication. J Gen Virol 91:1013\u20131018. https:\/\/doi.org\/10.1099\/vir.0.016881-0","journal-title":"J Gen Virol"},{"key":"337_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jbiotec.2003.12.008","volume":"110","author":"T Link","year":"2004","unstructured":"Link T, B\u00e4ckstr\u00f6m M, Graham R et al (2004) Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium. J Biotechnol 110:51\u201362. https:\/\/doi.org\/10.1016\/j.jbiotec.2003.12.008","journal-title":"J Biotechnol"},{"key":"337_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1586\/14760584.2015.965690","volume":"14","author":"K Ljungberg","year":"2015","unstructured":"Ljungberg K, Liljestr\u00f6m P (2015) Self-replicating alphavirus RNA vaccines. Expert Rev Vaccines 14:177\u2013194. https:\/\/doi.org\/10.1586\/14760584.2015.965690","journal-title":"Expert Rev Vaccines"},{"key":"337_CR32","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1016\/j.vaccine.2010.07.004","volume":"28","author":"V Lohr","year":"2010","unstructured":"Lohr V, Genzel Y, Behrendt I et al (2010) A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28:6256\u20136264. https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.004","journal-title":"Vaccine"},{"key":"337_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14760584.2.3.445","volume":"2","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom K (2003) Alphavirus vectors for vaccine production and gene therapy. Expert Rev Vaccines 2:447\u2013459","journal-title":"Expert Rev Vaccines"},{"key":"337_CR34","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000139","author":"K Lundstrom","year":"2012","unstructured":"Lundstrom K (2012a) Alphavirus vectors in vaccine development. J Vaccine Vaccinat. https:\/\/doi.org\/10.4172\/2157-7560.1000139","journal-title":"J Vaccine Vaccinat"},{"key":"337_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot070151","author":"K Lundstrom","year":"2012","unstructured":"Lundstrom K (2012b) Generation of recombinant alphaviral vectors. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot070151","journal-title":"Cold Spring Harb Protoc"},{"key":"337_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4040039","author":"K Lundstrom","year":"2016","unstructured":"Lundstrom K (2016) Replicon RNA viral vectors as vaccines. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines4040039","journal-title":"Vaccines (Basel)"},{"key":"337_CR37","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2017-0151","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K (2018) Latest development on RNA-based drugs and vaccines. Future Sci OA. https:\/\/doi.org\/10.4155\/fsoa-2017-0151","journal-title":"Future Sci OA"},{"key":"337_CR38","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/nar\/30.6.1292","volume":"30","author":"IM Mackay","year":"2002","unstructured":"Mackay IM, Arden KE, Nitsche A (2002) Real-time PCR in virology. Nucleic Acids Res 30:1292\u20131305","journal-title":"Nucleic Acids Res"},{"key":"337_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/mab.2015.0004","volume":"34","author":"L Manna","year":"2015","unstructured":"Manna L, Di Febo T, Armillotta G et al (2015) Production of monoclonal antibodies in serum-free media. Monoclon Antib Immunodiagn Immunother 34:278\u2013288. https:\/\/doi.org\/10.1089\/mab.2015.0004","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"337_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00772195","volume":"14","author":"OW Merten","year":"1994","unstructured":"Merten OW, Kierulff JV, Castignolles N, Perrin P (1994) Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines. Cytotechnology 14:47\u201359","journal-title":"Cytotechnology"},{"key":"337_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1008021317639","volume":"30","author":"OW Merten","year":"1999","unstructured":"Merten OW, Kallel H, Manuguerra JC et al (1999) The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnology 30:191\u2013201. https:\/\/doi.org\/10.1023\/A:1008021317639","journal-title":"Cytotechnology"},{"key":"337_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/14760584.2015.979798","volume":"14","author":"MA Mogler","year":"2015","unstructured":"Mogler MA, Kamrud KI (2015) RNA-based viral vectors. Expert Rev Vaccines 14:283\u2013312. https:\/\/doi.org\/10.1586\/14760584.2015.979798","journal-title":"Expert Rev Vaccines"},{"key":"337_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0141-0229(94)00071-X","volume":"17","author":"JL Moreira","year":"1995","unstructured":"Moreira JL, Alves PM, Feliciano AS et al (1995) Serum-free and serum-containing media for growth of suspended BHK aggregates in stirred vessels. Enzyme Microb Technol 17:437\u2013444. https:\/\/doi.org\/10.1016\/0141-0229(94)00071-X","journal-title":"Enzyme Microb Technol"},{"key":"337_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/0264-410X(94)00022-F","volume":"13","author":"P Perrin","year":"1995","unstructured":"Perrin P, Madhusudana S, Gontier-Jallet C et al (1995) An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 13:1244\u20131250","journal-title":"Vaccine"},{"key":"337_CR45","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1016\/j.vaccine.2013.09.051","volume":"31","author":"B Peschel","year":"2013","unstructured":"Peschel B, Frentzel S, Laske T et al (2013) Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line. Vaccine 31:5693\u20135699. https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.051","journal-title":"Vaccine"},{"key":"337_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1472-6750-11-84","volume":"11","author":"E Petiot","year":"2011","unstructured":"Petiot E, Jacob D, Lanthier S et al (2011) Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol 11:84. https:\/\/doi.org\/10.1186\/1472-6750-11-84","journal-title":"BMC Biotechnol"},{"key":"337_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jviromet.2013.07.058","volume":"193","author":"ALP Puglia","year":"2013","unstructured":"Puglia ALP, Rezende AG, Jorge SAC et al (2013) Quantitative RT-PCR for titration of replication-defective recombinant Semliki Forest virus. J Virol Methods 193:647\u2013652. https:\/\/doi.org\/10.1016\/j.jviromet.2013.07.058","journal-title":"J Virol Methods"},{"key":"337_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/rmv.360","volume":"12","author":"JO Rayner","year":"2002","unstructured":"Rayner JO, Dryga SA, Kamrud KI (2002) Alphavirus vectors and vaccination. Rev Med Virol 12:279\u2013296. https:\/\/doi.org\/10.1002\/rmv.360","journal-title":"Rev Med Virol"},{"key":"337_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1113\/expphysiol.2004.028142","volume":"90","author":"C Rh\u00eame","year":"2005","unstructured":"Rh\u00eame C, Ehrengruber MU, Grandgirard D (2005) Alphaviral cytotoxicity and its implication in vector development. Exp Physiol 90:45\u201352. https:\/\/doi.org\/10.1113\/expphysiol.2004.028142","journal-title":"Exp Physiol"},{"key":"337_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcv.2005.12.001","volume":"35","author":"A Riezebos-Brilman","year":"2006","unstructured":"Riezebos-Brilman A, de Mare A, Bungener L et al (2006) Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy. J Clin Virol 35:233\u2013243. https:\/\/doi.org\/10.1016\/j.jcv.2005.12.001","journal-title":"J Clin Virol"},{"key":"337_CR51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/bit.22499","volume":"104","author":"AF Rodrigues","year":"2009","unstructured":"Rodrigues AF, Carmo M, Alves PM, Coroadinha AS (2009) Retroviral vector production under serum deprivation: the role of lipids. Biotechnol Bioeng 104:1171\u20131181. https:\/\/doi.org\/10.1002\/bit.22499","journal-title":"Biotechnol Bioeng"},{"key":"337_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijpharm.2012.08.002","volume":"437","author":"ME Rodrigues","year":"2012","unstructured":"Rodrigues ME, Costa AR, Henriques M et al (2012) Comparison of commercial serum-free media for CHO-K1 cell growth and monoclonal antibody production. Int J Pharm 437:303\u2013305. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.08.002","journal-title":"Int J Pharm"},{"key":"337_CR53","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.vaccine.2014.02.040","volume":"32","author":"S Rourou","year":"2014","unstructured":"Rourou S, Ben Ayed Y, Trabelsi K et al (2014) An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines. Vaccine 32:2767\u20132769. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.040","journal-title":"Vaccine"},{"key":"337_CR54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin U, Karik\u00f3 K, T\u00fcreci \u00d6 (2014) mRNA-based therapeutics\u2014developing a new class of drugs. Nat Rev Drug Discov 13:759\u2013780. https:\/\/doi.org\/10.1038\/nrd4278","journal-title":"Nat Rev Drug Discov"},{"key":"337_CR55","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","volume":"9","author":"L Sastry","year":"2002","unstructured":"Sastry L, Johnson T, Hobson MJ et al (2002) Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9:1155\u20131162. https:\/\/doi.org\/10.1038\/sj.gt.3301731","journal-title":"Gene Ther"},{"key":"337_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1385\/MB:15:3:249","volume":"15","author":"MS Sinacore","year":"2000","unstructured":"Sinacore MS, Drapeau D, Adamson SR (2000) Adaptation of mammalian cells to growth in serum-free media. Mol Biotechnol 15:249\u2013257. https:\/\/doi.org\/10.1385\/MB:15:3:249","journal-title":"Mol Biotechnol"},{"key":"337_CR57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1750-2659.2010.00149.x","volume":"4","author":"MJ Slomka","year":"2010","unstructured":"Slomka MJ, Densham ALE, Coward VJ et al (2010) Real time reverse transcription (RRT)-polymerase chain reaction (PCR) methods for detection of pandemic (H1N1) 2009 influenza virus and European swine influenza A virus infections in pigs. Influenza Other Respir Viruses 4:277\u2013293. https:\/\/doi.org\/10.1111\/j.1750-2659.2010.00149.x","journal-title":"Influenza Other Respir Viruses"},{"key":"337_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaccine.2012.11.096","volume":"31","author":"SF Slovin","year":"2013","unstructured":"Slovin SF, Kehoe M, Durso R et al (2013) A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine 31:943\u2013949. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.096","journal-title":"Vaccine"},{"key":"337_CR59","doi-asserted-by":"publisher","DOI":"10.4172\/2157-2526.S1-001","author":"KB Spurgers","year":"2011","unstructured":"Spurgers KB, Glass PJ (2011) Vaccine development for biothreat alphaviruses. J Bioterrorism Biodefense. https:\/\/doi.org\/10.4172\/2157-2526.S1-001","journal-title":"J Bioterrorism Biodefense"},{"key":"337_CR60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1126\/science.8456302","volume":"259","author":"JB Ulmer","year":"1993","unstructured":"Ulmer JB, Donnelly JJ, Parker SE et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745\u20131749","journal-title":"Science"},{"key":"337_CR61","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.tiv.2010.03.016","volume":"24","author":"J van der Valk","year":"2010","unstructured":"van der Valk J, Brunner D, De Smet K et al (2010) Optimization of chemically defined cell culture media\u2013replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24:1053\u20131063. https:\/\/doi.org\/10.1016\/j.tiv.2010.03.016","journal-title":"Toxicol In Vitro"},{"key":"337_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1466252312000011","volume":"13","author":"RL Vander Veen","year":"2012","unstructured":"Vander Veen RL, Harris DLH, Kamrud KI (2012) Alphavirus replicon vaccines. Anim Health Res Rev 13:1\u20139. https:\/\/doi.org\/10.1017\/S1466252312000011","journal-title":"Anim Health Res Rev"},{"key":"337_CR63","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P et al (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465\u20131468","journal-title":"Science"},{"key":"337_CR64","doi-asserted-by":"publisher","DOI":"10.2174\/1389201018666170320110545","author":"G Zhang","year":"2017","unstructured":"Zhang G, Liu J, Fan W et al (2017) An efficient transient expression system for enhancing generation of monoclonal antibodies in 293 suspension cells. Curr Pharm Biotechnol. https:\/\/doi.org\/10.2174\/1389201018666170320110545","journal-title":"Curr Pharm Biotechnol"},{"key":"337_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/v2020413","volume":"2","author":"G Zimmer","year":"2010","unstructured":"Zimmer G (2010) RNA replicons\u2014a new approach for influenza virus immunoprophylaxis. Viruses 2:413\u2013434. https:\/\/doi.org\/10.3390\/v2020413","journal-title":"Viruses"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-019-00337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10616-019-00337-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-019-00337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:51:46Z","timestamp":1744087906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10616-019-00337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,17]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1007\/s10616-019-00337-y","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"type":"print","value":"0920-9069"},{"type":"electronic","value":"1573-0778"}],"subject":[],"published":{"date-parts":[[2019,8,17]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}